Dahan Michel

CIK 00016697371 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001669737

Recent Transactions

45 trades

Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-05-13$1.26/sh−34,840→ 672,092 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-29$1.58/sh−8,661→ 706,932 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-27$1.52/sh−10,744→ 715,593 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-01-31+149,300→ 726,337 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2024-01-31+224,000→ 224,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-05-25$1.22/sh−95,478→ 574,037 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-05-24+200,000→ 669,515 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2023-05-24+200,000→ 200,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-05-12+200,000→ 469,515 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−1,878→ 269,515 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−10,476→ 271,393 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−8,058→ 281,869 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-02-27$0.81/sh−10,090→ 289,927 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−6,873→ 302,122 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−6,873→ 295,249 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−1,232→ 297,017 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2022-02-28+200,000→ 200,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-02-28+50,000→ 308,995 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-02-28$2.15/sh−6,555→ 258,995 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-04-01$3.40/sh−1,211→ 265,550 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-16+11,648→ 266,761 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-01$3.40/sh−6,602→ 263,058 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-01$3.40/sh−7,945→ 255,113 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-02-26+62,000→ 269,660 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2021-02-26+110,000→ 110,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-02-28+65,000→ 211,932 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2020-02-28+120,000→ 120,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-02-28$8.70/sh−6,972→ 204,960 total
Disposition to Issuer
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-04-11$7.70/sh−11,909→ 146,932 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2019-02-28+100,000→ 100,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-02-28+65,000→ 158,841 total
Tax Payment
Akebia Therapeutics, Inc.$AKBA
Common Stock
2018-12-12$8.94/sh−23,385→ 93,841 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2018-02-28+19,400→ 115,226 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2018-02-28+27,500→ 27,500 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-10-02$19.64/sh−1,398→ 95,826 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-09-28$19.30/sh−5,000→ 97,224 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-08-15$15.00/sh−5,000→ 102,224 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-07-03$14.26/sh−1,399→ 107,224 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-04-03$9.18/sh−1,401→ 108,623 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-02-21+39,500→ 110,024 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2017-02-21$10.14/sh+62,500→ 62,500 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-01-01$10.49/sh−1,629→ 70,524 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-10-01$8.95/sh−1,401→ 72,153 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-07-05$7.47/sh−1,402→ 73,554 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-04-04$9.41/sh−1,401→ 74,956 total

Companies

Akebia Therapeutics, Inc.
SVP, Chief Business Officer
$AKBA

Recent Filings

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100

CAMBRIDGE, MA, 02142

View on SEC.gov